ADR Biomedical Holdings Inc.

2026/08/25 Updated
Market Cap: $42.6M (¥6.8B)
Stock Price: $4.77 (¥760)
Exchange Rate: 1 USD = ¥159.24

Notice Regarding Continuation of Shareholder Benefit Program

A shareholder benefit program has been introduced since 2024, and the board has resolved to continue it. The standard applies to shareholders recorded on the shareholder register with 100 shares or more as of each record date, and a QUO card worth 2,500 yen is provided per record date.

Importance:
Page Updated: August 25, 2026
IR Disclosure Date: August 25, 2026

Key Figures

  • Shareholder benefit: QUO card 2,500 yen per record date
  • Record dates: End of September, End of March
  • Eligible shareholders: holders of 100 shares or more

AI要約

Overview of the Shareholder Benefit Program

ADR Biomedic al Holdings Limited introduced a shareholder benefit program in 2024. The program provides the benefit twice a year on the record dates of the end of September and the end of March, targeting shareholders who hold 100 shares or more as of the record date. The benefit is QUO card valued at 2,500 yen per record date.

Continuation Resolution and Eligible Shareholders

At today's board meeting, the continuation of the shareholder benefit program was resolved. The program aims to reward shareholders and to encourage long-term holding. Eligible shareholders are those holding 100 shares or more as of each record date, with entries as of the end of September and the end of March applying.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

ADR Biomedic al Holdings Limited

Company overview · Stock price · Financial data · All IR

View company page →